Nanjing Pharmaceutical Co (SHSE:600713) Other Income (Minority Interest) : ¥-138 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Nanjing Pharmaceutical Co Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. Nanjing Pharmaceutical Co's Other Income (Minority Interest) for the three months ended in Mar. 2024 was ¥-38 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-138 Mil.

Nanjing Pharmaceutical Co Other Income (Minority Interest) Historical Data

The historical data trend for Nanjing Pharmaceutical Co's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Pharmaceutical Co Other Income (Minority Interest) Chart

Nanjing Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Minority Interest)

Get a 7-Day Free Trial

-84.63

-93.63

-105.37

-120.25

-134.98

Nanjing Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Minority Interest)	Get a 7-Day Free Trial															-34.45	-32.70	-25.52	-42.31	-37.86

Nanjing Pharmaceutical Co Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-138 Mil.

Nanjing Pharmaceutical Co (SHSE:600713) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Nanjing Pharmaceutical Co (SHSE:600713) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Pharmaceutical Co Ltd (SHSE:600713) » Definitions » Other Income (Minority Interest)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 486 Zhongshan East Road, Nanjing, Jiangsu, CHN, 210002

Website

http://www.guangyuyuan.com

Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.

Executives

Xiao Hong	senior management
Peng Yu Ping	senior management
She Ping	Supervisors
Jiang Xiao Jun	senior management
Teng Xue Wu	senior management
Zhou Jian Jun	senior management
Li Yi	Director
Huang Yan Li	Supervisors
Tang Jian Zhong	senior management
Zhang Yan Hui	senior management
Zhou Yao Ping	Director
Wang Hui Qing	senior management
He Jin Geng	senior management
Ding Feng Jun	Director
Liang Yu Tang	Director

Nanjing Pharmaceutical Co (SHSE:600713) Headlines

No Headlines